UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date
of earliest event reported)
February 15,
2008
ULTRALIFE
BATTERIES, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware |
||
|
(State or other jurisdiction of incorporation or organization) |
||
|
000-20852 |
|
16-1387013 |
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
2000 Technology Parkway, Newark, New York |
14513 |
|
(Address of principal executive offices) |
(Zip Code) |
(315) 332-7100
(Registrant’s
telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item
2.02 Results of Operations and Financial Condition.
Ultralife
(the "Company") announced that, based on a preliminary review of results
for the fourth quarter ended December 31, 2007, the company expects to
report revenue in the range of $36.5 million and an operating loss in
the range of $2.5 million. These preliminary results compare to the
guidance management provided in its third quarter report that called for
revenue of approximately $41 million to $44 million and operating profit
of between $2.7 million and $3.5 million.
The Company’s press release is attached as Exhibit 99.1 to this Form 8-K. The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed to be incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.
Item 9.01 Financial Statements and
Exhibits.
| (a) | Exhibits. |
|
|
99.1 Press Release dated February 15, 2008. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
ULTRALIFE BATTERIES, INC. |
|
Dated: |
February 15, 2008 |
|
|
|
|
/s/ Robert W. Fishback |
|
Robert W. Fishback |
||
|
Vice President of Finance and CFO |
2
INDEX TO EXHIBITS
(99) Additional Exhibits
99.1 Press Release dated February 15, 2008.
3